Helminthostachys zeylanica alleviates hepatic steatosis and insulin resistance in diet-induced obese mice
Open Access
- 13 December 2019
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Complementary and Alternative Medicine
- Vol. 19 (1), 1-11
- https://doi.org/10.1186/s12906-019-2782-3
Abstract
Obesity and its associated health conditions, type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD), are worldwide health problems. It has been shown that insulin resistance is associated with increased hepatic lipid and causes hepatic steatosis through a myriad of mechanisms, including inflammatory signaling. Helminthostachys zeylanica (HZ) is used widely as a common herbal medicine to relieve fever symptoms and inflammatory diseases in Asia. In the present study, we evaluated whether HZ has therapeutic effects on obesity, NAFLD and insulin resistance. The protective effects of HZ extract were examined using free fatty acid-induced steatosis in human HuS-E/2 cells and a high-fat diet-induced NAFLD in mice. The major components of the HZ extract are ugonins J and K, confirmed by HPLC. Incubation of human hepatocytes, HuS-E/2 cells, with palmitate markedly increased lipid accumulation and treatment with the HZ extract significantly decreased lipid deposition and facilitated AMPK and ACC activation. After 12 weeks of a high-fat diet with HZ extract treatment, the HFD mice were protected from hyperlipidemia and hyperglycemia. HZ extract prevented body weight gain, adipose tissue expansion and adipocyte hypertrophy in the HFD mice. In addition, fat accumulation was reduced in mice livers. Moreover, the insulin sensitivity-associated index, which evaluates insulin function, was also significantly restored. These results suggest that HZ has a promising pharmacological effect on high-fat diet-induced obesity, hepatic steatosis and insulin resistance, which may have the potential for clinical application.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST 104-2320-B-077-003-, MOST 106-2320-B-010-038-)
This publication has 51 references indexed in Scilit:
- Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individualsAnnals of the New York Academy of Sciences, 2013
- The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP–PKA-dependent signaling pathwayFree Radical Biology & Medicine, 2012
- Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver diseaseExperimental and Therapeutic Medicine, 2011
- Multi-targeted prevention and therapy of cancer by proanthocyanidinsCancer Letters, 2008
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort StudyThe American Journal of Gastroenterology, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJCI Insight, 2008
- Improved Insulin Resistance and Lipid Metabolism by Cinnamon Extract through Activation of Peroxisome Proliferator-Activated ReceptorsPPAR Research, 2008
- AMP-activated/SNF1 protein kinases: conserved guardians of cellular energyNature Reviews Molecular Cell Biology, 2007
- Treatment of non-alcoholic fatty liver diseasePostgraduate Medical Journal, 2006
- Dysrhythmias Following Muscle Relaxant Administration in Patients Receiving DigitalisAnesthesiology, 1983